Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Adrenal Gland Neoplasm”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableLooking for participantsNCT06801340
What this trial is testing

Assessment of Metabolic Complications in Patients With Adrenal Tumors Through Radiological Images

Who this might be right for
Adrenal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06831175
What this trial is testing

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Who this might be right for
Adrenal Cortical CarcinomaAdrenal Cortical CancerAdrenal Cancer
West China Hospital 28
Testing effectiveness (Phase 2)Ended earlyNCT01340794
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Who this might be right for
Extra-Adrenal ParagangliomaMetastatic Adrenal Gland PheochromocytomaParaganglioma+1 more
National Cancer Institute (NCI) 7
Not applicableEnded earlyNCT01348698
What this trial is testing

Evaluation of Molecular Markers in Adrenal Tumors

Who this might be right for
Adrenal Gland Neoplasms
National Cancer Institute (NCI) 74
Not applicableLooking for participantsNCT02402244
What this trial is testing

Project: Every Child for Younger Patients With Cancer

Who this might be right for
Adrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15 more
Children's Oncology Group 75,000
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableActive Not RecruitingNCT00568139
What this trial is testing

Evaluation of Side Effects of Mitotane

Who this might be right for
Adrenocortical Carcinoma
University of Wuerzburg 400
Early research (Phase 1)Study completedNCT01586455
What this trial is testing

Human Placental-Derived Stem Cell Transplantation

Who this might be right for
Mucopolysaccharidosis IMucopolysaccharidosis VIAdrenoleukodystrophy+13 more
New York Medical College 43
Not applicableLooking for participantsNCT05754892
What this trial is testing

Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE)

Who this might be right for
CancerAdrenal
Assistance Publique - Hôpitaux de Paris 450
Not applicableUnknownNCT04090268
What this trial is testing

Precision Exercise in Children With Malignant Hemopathies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T Cell+5 more
University of Milano Bicocca 380
Not applicableNot Yet RecruitingNCT07812779
What this trial is testing

Thyroid Health Outcomes Registry for Surgery

Who this might be right for
Thyroid DiseasesThyroid NeoplasmsThyroid Cancer+9 more
Pirogov Russian National Research Medical University 3,000
Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Looking for participantsNCT06041516
What this trial is testing

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT04187404
What this trial is testing

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
Enterome 70
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Next Page